![Sheldon Sloan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheldon Sloan
Directeur Technique/Scientifique/R&D chez
SPYRE THERAPEUTICS, INC.
Profil
Sheldon Sloan is Chief Medical Officer at Spyre Therapeutics, Inc. since 2024.
Formerly, Chief Medical Officer at Abivax SA from 2023 to 2024.
Education includes graduate degree from the University of Pennsylvania, undergraduate degree from Illinois Urbana Champaign University of, and doctorate from Rush Medical College.
Postes actifs de Sheldon Sloan
| Sociétés | Poste | Début |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2024 |
Anciens postes connus de Sheldon Sloan
| Sociétés | Poste | Fin |
|---|---|---|
| ABIVAX | Directeur Technique/Scientifique/R&D | 15/07/2024 |
Formation de Sheldon Sloan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rush Medical College
 Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Choisissez Zonebourse 
